Literature DB >> 15819637

Polypharmacy in the elderly: a literature review.

Maryann M Fulton, Elizabeth Riley Allen.   

Abstract

PURPOSE: To review the body of literature addressing polypharmacy in individuals aged 60 years and older to (a) determine primary care providers' definition of polypharmacy, (b) explore how polypharmacy was assessed in primary care, and (c) seek tested interventions that address polypharmacy. DATA SOURCES: A systematic review of electronic bibliographic databases (e.g. EBSCOHost, InfoTrac, OVID, FirstSearch, and FirstSearch Deluxe) utilizing the search terms "polypharmacy," "polypharmacy and elderly," "polypharmacy and research," and "multiple medications" for the period January 1991 to October 2003 was completed. The search was supplemented with online site searches of relevant journals and review of reference lists of each article.
CONCLUSIONS: Results of the literature review revealed that polypharmacy continues to be a significant issue and little research has been conducted regarding the methods primary care providers utilize to assess polypharmacy. Also, there is a gap in the literature regarding the interventions implemented by primary care providers to address polypharmacy. IMPLICATIONS FOR PRACTICE: The following definition of polypharmacy in clinical practice might be more practical: the use of medications that are not clinically indicated. Selecting appropriate limits for numbers of medications may be counterproductive in populations with multiple comorbidities.

Mesh:

Year:  2005        PMID: 15819637     DOI: 10.1111/j.1041-2972.2005.0020.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  137 in total

Review 1.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

Review 2.  Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors:  Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

4.  Polypharmacy among disabled Taiwanese elderly: a longitudinal observational study.

Authors:  Ding-Cheng Derrick Chan; Yi-Ting Hao; Shwu-Chong Wu
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Aging and Adherence to the Mediterranean Diet: Relationship with Cardiometabolic Disorders and Polypharmacy.

Authors:  R Vicinanza; G Troisi; R Cangemi; M U De Martino; D Pastori; S Bernardini; F Crisciotti; F Di Violante; A Frizza; M Cacciafesta; P Pignatelli; V Marigliano
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 6.  Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Authors:  Tim Johansson; Muna E Abuzahra; Sophie Keller; Eva Mann; Barbara Faller; Christina Sommerauer; Jennifer Höck; Christin Löffler; Anna Köchling; Jochen Schuler; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

Review 7.  Drug-drug interaction software in clinical practice: a systematic review.

Authors:  Tina Roblek; Tomaz Vaupotic; Ales Mrhar; Mitja Lainscak
Journal:  Eur J Clin Pharmacol       Date:  2014-12-23       Impact factor: 2.953

8.  Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

Authors:  Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortíz; Inmaculada Bellido-Estévez
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

Review 9.  Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy.

Authors:  Stuart M Lichtman; Manpreet K Boparai
Journal:  Curr Treat Options Oncol       Date:  2008-07-29

10.  The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study.

Authors:  Elbert S Huang; Andrew J Karter; Kirstie K Danielson; E Margaret Warton; Ameena T Ahmed
Journal:  J Gen Intern Med       Date:  2009-12-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.